377 results
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
with healthcare-based investment banking.
Brian Lian, Ph.D. has been a director since January 2019. He is the Chair of our Compensation Committee and our Audit … a director since March 2013. He is a member of our Audit Committee and our Compensation Committee. Mr. Pascoe served as the Chief Executive Officer
8-K
EX-10.1
vx0uyqb
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
ddl56 5mxqb
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
EX-1.1
nfe9nh27gw
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
3vvkf
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
toj3wd0zhchugalfo0no
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
0ufhoclhim9p 0rjy
29 Sep 23
Prospectus supplement
4:56pm
8-K
EX-10.1
2hhc4b0gq7pw9gix
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
wgo54
25 Sep 23
Prospectus supplement for primary offering
6:02am